Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

5-alpha reductase deficiency leads to male sexual development issues and treatments like finasteride help with prostate enlargement and hair loss.

Some plant-derived compounds may help with hormonal conditions, but more research is needed to confirm their effectiveness.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

The document concludes that treating PCOS requires a combination of drugs to manage reproductive and metabolic symptoms, with more research needed on combination therapies.

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Metformin should be used for PCOS mainly in those with glucose intolerance, and has limited benefits for infertility or hirsutism.

High doses of finasteride cause cell growth and tumors in mice.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Minoxidil effectively treats female pattern hair loss.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

Doctors should know how to diagnose and treat PCOS, which often involves checking for high male hormone levels and using medications to manage symptoms.

Finasteride shows promise for female hair loss, but more research needed.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Dutasteride makes alcohol less sedating and may lead to less drinking in men.

Combining laser hair removal with topical eflornithine is recommended for better results in treating unwanted facial hair.

Using finasteride with TIP extends time off period for prostate cancer patients.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

Finasteride effectively treats male hair loss, improving growth and density.

Curcumin may improve blood sugar levels and cholesterol in people with PCOS, but more research is needed.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.